Westat’s Regulatory Department collaborates with sponsors and in-house project staff to ensure that every aspect of protocol development, clinical trial management, and documentation complies with local, Federal, and the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals (ICH) requirements. Our regulatory staff has firsthand, in-depth knowledge of the regulatory requirements for the United States.
Westat uses a proprietary tracking system, Site Information Management for Clinical Trials (SIMCT), to track all regulatory documents received for site establishment and protocol registration.
The SIMCT system performs the following:
Westat uses Oracle’s Adverse Event Reporting System (AERS) to efficiently collect, maintain, track, and report serious adverse event (SAE) data. Data can also be reconciled with clinical databases. The system also tracks event dates and provides prompts when reports are due.
AERS automatically populates two key forms from data entered into the system:
This task ensures efficiency and accuracy in form preparation.
AERS meets Federal reporting requirements.